Feds Invite Schools to Join Research Club
Published Date: 7/1/2026
Notice
Summary
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Apply to Join FDP Phase VIII
Eligible organizations that receive federal research or research-related funding — including large and small public and private colleges and universities (including predominantly undergraduate institutions, minority-serving institutions, and emerging research institutions), non-profit research and education organizations, and research hospitals and medical centers — may apply to participate in Phase VIII. Applications must be received by C.O.B. on September 15, 2026; selection is expected on or about October 31, 2026 and agreements on or about December 15, 2026. Phase VIII begins with an organizational meeting in January 2027 and concludes December 31, 2032, and will continue testing approaches to streamline processes and systems for federally supported research.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13204 — Proposed Collection; 30-Day Comment Request; NIH Information Collection Forms to Support the Genetic Testing Registry (OD)
The NIH wants your thoughts on updating forms that help track genetic tests in their registry. If you’re involved in genetic testing or research, these changes could affect how you share info. You’ve got until July 30, 2026, to send in your comments—no cost, just your voice to help make things smoother and smarter!
2026-12844 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on July 17, 2026, to review important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants in brain injury, neurobehavior, nanotech, and heart/lung studies should note these review dates and prepare accordingly.
2026-12843 — Government Owned Inventions Available for License: C8166-45 Cell Line
The National Cancer Institute is offering a special human T-cell line called C8166-45 for licensing. This cell line helps scientists study viruses like HTLV-1 and HIV, which can cause serious diseases. Researchers and companies can now use this tool to develop better treatments, with licensing info available starting June 2026—no patents, just pure science power ready to roll!
2026-12842 — Government Owned Inventions Available for License: Compositions and Methods for Producing Dendritic Cell-based Vaccines With Enhanced Efficacy
The National Cancer Institute has created a new way to make cancer vaccines stronger by using special omega-3 fats to boost immune cells called dendritic cells. This could help scientists and companies develop better cancer treatments that work more effectively. If you’re in biotech or medicine, now’s the time to team up or license this exciting technology and help bring improved vaccines to patients faster.
Previous / Next Documents
Previous: 2026-13243 — Rural Health Innovation and Transformation Technical Assistance
The University of Iowa is getting an extra $150,000 from HRSA to help improve health care in rural areas by supporting new ways to pay for and deliver care. This funding runs from August 2026 to July 2027 and will help rural health providers tackle unique challenges with value-based care. It’s a boost to keep rural health innovation moving forward and make care better for folks living outside big cities.
Next: 2026-13246 — Information Collection Request to Office of Management and Budget; OMB Control Number: 1625-0112
The U.S. Coast Guard wants to keep collecting electronic vessel transit data to keep our waters safe, with no changes to the current process. This affects anyone who reports vessel movements and helps the Coast Guard track ships better. They’re asking for your thoughts by August 31, 2026, before asking the government to approve this again—no new costs or extra paperwork are planned.